ENDRA Life Sciences (NDRA) Free Cash Flow (2016 - 2021)
Historic Free Cash Flow for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$2.7 million.
- ENDRA Life Sciences' Free Cash Flow fell 2407.77% to -$2.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year decrease of 319.22%. This contributed to the annual value of -$7.4 million for FY2024, which is 2260.45% up from last year.
- ENDRA Life Sciences' Free Cash Flow amounted to -$2.7 million in Q4 2021, which was down 2407.77% from -$2.7 million recorded in Q3 2021.
- In the past 5 years, ENDRA Life Sciences' Free Cash Flow ranged from a high of -$236274.0 in Q1 2017 and a low of -$3.5 million during Q2 2020
- Its 5-year average for Free Cash Flow is -$2.1 million, with a median of -$2.1 million in 2020.
- Per our database at Business Quant, ENDRA Life Sciences' Free Cash Flow crashed by 93773.16% in 2018 and then surged by 1889.68% in 2021.
- Over the past 5 years, ENDRA Life Sciences' Free Cash Flow (Quarter) stood at -$1.4 million in 2017, then plummeted by 38.3% to -$1.9 million in 2018, then fell by 2.28% to -$1.9 million in 2019, then dropped by 9.87% to -$2.1 million in 2020, then dropped by 24.08% to -$2.7 million in 2021.
- Its Free Cash Flow stands at -$2.7 million for Q4 2021, versus -$2.7 million for Q3 2021 and -$2.8 million for Q2 2021.